Q4 2022 Holdings
Filed 2023-02-14 | 104 holdings | $4.8B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Nuvalent Inc(NUVL) | COM | 670703107 | $595.3M | 19,991,024 | 12.3% |
| Glaukos Corp | NOTE 2.750% 6/1 | 377322AB8 | $312.6M | $271,752,000 | 6.5% |
| Invitae Corp | NOTE 2.000% 9/0 | 46185LAB9 | $190.8M | $241,873,000 | 4.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $180.7M | 1,512,714 | 3.7% |
| Sarepta Therapeutics Inc | DBCV 1.500%11/1 | 803607AB6 | $165.4M | 88,657,000 | 3.4% |
| Adapthealth Corp(AHCO) | COMMON STOCK | 00653Q102 | $146.6M | 7,626,914 | 3.0% |
| Ionis Pharmaceuticals Inc | NOTE 4/0 | 462222AD2 | $118.3M | $127,800,000 | 2.4% |
| Tabula Rasa Healthcare Inc | NOTE 1.750% 2/1 | 873379AA9 | $114.6M | $144,516,000 | 2.4% |
| Brookdale SR Living Inc | NOTE 2.000%10/1 | 112463AC8 | $112.2M | $145,955,000 | 2.3% |
| Viatris Inc(VTRS) | COM | 92556V106 | $111.3M | 10,000,000 | 2.3% |
| Catalyst Pharmaceuticals Inc(CPRX) | COM | 14888U101 | $109.5M | 5,884,448 | 2.3% |
| Natera Inc | NOTE 2.250% 5/0 | 632307AB0 | $108.1M | $84,913,000 | 2.2% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $99.5M | 2,693,000 | 2.1% |
| Insmed Inc | NOTE 1.750% 1/1 | 457669AA7 | $95.8M | $102,700,000 | 2.0% |
| Intercept Pharmaceuticals in | NOTE 3.500% 2/1 | 45845PAC2 | $95.2M | $98,354,000 | 2.0% |
| Nuvasive Inc | NOTE 1.000% 6/0 | 670704AL9 | $95.2M | $96,966,000 | 2.0% |
| Amedisys Inc(AMED) | COM | 023436108 | $94.9M | 1,136,080 | 2.0% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $94.5M | 11,077,927 | 2.0% |
| Apellis Pharmaceuticals Inc | NOTE 3.500% 9/1 | 03753UAB2 | $79.4M | $51,885,000 | 1.6% |
| OAK STR Health Inc | NOTE 3/1 | 67181AAB3 | $76.0M | $100,000,000 | 1.6% |
| Silk RD MED Inc | COM | 82710M100 | $73.8M | 1,396,640 | 1.5% |
| Pacira Biosciences Inc | NOTE 0.750% 8/0 | 695127AF7 | $73.6M | $81,600,000 | 1.5% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $73.3M | 3,424,852 | 1.5% |
| Accolade Inc | NOTE 0.500% 4/0 | 00437EAB8 | $73.3M | $105,000,000 | 1.5% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $70.0M | 16,941,357 | 1.4% |
| Caremax Inc | COM CL A | 14171W103 | $57.9M | 15,861,090 | 1.2% |
| Nanostring Technologies Inc | NOTE 2.625% 3/0 | 63009RAD1 | $56.7M | $70,204,000 | 1.2% |
| Intercept Pharmaceuticals in | NOTE 3.250% 7/0 | 45845PAA6 | $56.4M | $57,791,000 | 1.2% |
| Guardant Health Inc | NOTE 11/1 | 40131MAB5 | $55.8M | $89,036,000 | 1.2% |
| Centene Corp del(CNC) | COM | 15135B101 | $46.3M | 565,000 | 1.0% |
| Hillevax Inc | COM | 43157M102 | $45.1M | 2,694,101 | 0.9% |
| Phreesia Inc(PHR) | COM | 71944F106 | $44.2M | 1,366,329 | 0.9% |
| Livongo Health Inc | NOTE 0.875% 6/0 | 539183AA1 | $43.8M | $50,000,000 | 0.9% |
| Alphatec Hldgs Inc | NOTE 0.750% 8/0 | 02081GAB8 | $43.7M | $48,050,000 | 0.9% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $39.6M | 2,032,335 | 0.8% |
| Enhabit Inc(EHAB) | COM | 29332G102 | $39.4M | 2,996,000 | 0.8% |
| 1Life Healthcare Inc | NOTE 3.000% 6/1 | 68269GAB3 | $39.2M | $40,599,000 | 0.8% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $38.5M | 2,349,228 | 0.8% |
| Merus N V | COM | N5749R100 | $36.8M | 2,380,438 | 0.8% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $36.0M | 1,161,826 | 0.7% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $35.2M | 3,933,137 | 0.7% |
| Brookdale SR Living Inc(BKD) | COM | 112463104 | $34.6M | 12,679,651 | 0.7% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $34.3M | 2,966,345 | 0.7% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $33.6M | 700,000 | 0.7% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $31.7M | 1,743,628 | 0.7% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $31.5M | 6,358,314 | 0.7% |
| PTC Therapeutics Inc | NOTE 1.500% 9/1 | 69366JAD3 | $31.4M | $32,000,000 | 0.6% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $29.6M | 2,383,000 | 0.6% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $29.4M | 3,581,000 | 0.6% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $29.0M | 2,851,287 | 0.6% |